Cited by

• A revised boron-neutron capture therapy for malignant brain tumors. II. Interim clinical result with the patients excluding previous treatments.

  Hatanaka H. Hatanaka H. J Neurol. 1975 Jun 9;209(2):81-94. doi: 10.1007/BF00314601. J Neurol. 1975. PMID: 51055
• An analysis of the structure of the compound biological effectiveness factor.

  Ono K. Ono K. J Radiat Res. 2016 Aug;57 Suppl 1(Suppl 1):i83-i89. doi: 10.1093/jrr/rrw022. Epub 2016 Mar 28. J Radiat Res. 2016. PMID: 27021218 Free PMC article.
• Boron-neutron capture therapy in relation to immunotherapy.

  Hatanaka H, Amano K, Kamano S, Fankhauser H, Hanamura T, Sano K. Hatanaka H, et al. Acta Neurochir (Wien). 1978;42(1-2):57-72. doi: 10.1007/BF01406631. Acta Neurochir (Wien). 1978. PMID: 696445
• Relative biological effectiveness for epithermal neutron beam contaminated with fast neutrons in the linear accelerator-based boron neutron capture therapy system coupled to a solid-state lithium target.

  Nakamura S, Imamichi S, Shimada K, Takemori M, Kanai Y, Iijima K, Chiba T, Nakayama H, Nakaichi T, Mikasa S, Urago Y, Kashihara T, Takahashi K, Nishio T, Okamoto H, Itami J, Ishiai M, Suzuki M, Igaki H, Masutani M. Nakamura S, et al. J Radiat Res. 2023 Jul 18;64(4):661-667. doi: 10.1093/jrr/rrad037. J Radiat Res. 2023. PMID: 37295954 Free PMC article.
• Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target.

  Nakamura S, Igaki H, Ito M, Imamichi S, Kashihara T, Okamoto H, Nishioka S, Iijima K, Chiba T, Nakayama H, Takemori M, Abe Y, Kaneda T, Takahashi K, Inaba K, Okuma K, Murakami N, Nakayama Y, Masutani M, Nishio T, Itami J. Nakamura S, et al. Sci Rep. 2021 Apr 13;11(1):8090. doi: 10.1038/s41598-021-87627-8. Sci Rep. 2021. PMID: 33850253 Free PMC article.